Filter Results
:
(627)
Show Results For
- All HBS Web (627)
- Faculty Publications (304)
Show Results For
- All HBS Web (627)
- Faculty Publications (304)
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses.
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Health Industry;
Health Industry;
Health Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- 31 Aug 2021
- Book
Feeling Powerless at Work? Time to Agitate, Innovate, and Orchestrate
and children by not only providing medical care, but also working to rehabilitate people’s homes and provide vocational training for parents. She initially shied away from...
View Details
Keywords:
by Jay Fitzgerald
- 16 May 2018
- News
ALUMNI NVC Finals and Regional Roundup
hassle out of moving and furnishing a new residence. The runner-up spot went to Tom DeBrooke (MBA 1972) and his company, Vascular Perfusion Solutions, Inc., which has developed a new system to extend the...
View Details
Keywords:
Margie Kelley
- January 2011 (Revised January 2012)
- Case
The Case of the Unidentified Healthcare Companies2010
By: Richard Bohmer, Ethan Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected ratios for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a...
View Details
Bohmer, Richard, Ethan Bernstein, Margarita Krivitski, and Srinidhi Reddy. "The Case of the Unidentified Healthcare Companies2010." Harvard Business School Case 611-043, January 2011. (Revised January 2012.)
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
labor between innovative new entrants and industry incumbents, endowed with complementary assets, is common in many industries. Such settings are distinct because new entrants have the additional option to...
View Details
Keywords:
Dina Gerdeman
- February 2002 (Revised August 2002)
- Case
Inhale Therapeutics: Executing and Growing the Business Model
Inhale is about to bring a novel technology to market that uses inhalation to administer drugs that formerly required injection. Inhale must now decide which way to evolve its business model. This will determine the future direction of growth for the company.
View Details
Keywords:
Business Model;
Technological Innovation;
Health Care and Treatment;
Growth and Development Strategy;
Medical Devices and Supplies Industry
Chesbrough, Henry W., and Gillian Morris. "Inhale Therapeutics: Executing and Growing the Business Model." Harvard Business School Case 602-132, February 2002. (Revised August 2002.)
- January 2011 (Revised January 2012)
- Supplement
The Case of the Unidentified Healthcare Companies2010 (CW)
By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a...
View Details
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses
View Details
- August 2017
- Case
RoboTech: Storming into the U.S. Market
By: Christopher A. Bartlett, Rachel Gordon and John J. Lafkas
This case describes the challenges facing the CEO of a small, Singapore-based industrial robotics company that decides to diversify away from its core industrial robot business by leveraging its expertise into the medical-devices industry. It launches an innovative...
View Details
Keywords:
Market Entry and Exit;
Diversification;
Product Launch;
Competitive Strategy;
Globalized Firms and Management;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Singapore;
United States
Bartlett, Christopher A., Rachel Gordon, and John J. Lafkas. "RoboTech: Storming into the U.S. Market." Harvard Business School Brief Case 918-501, August 2017.
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091.
View Details
- Web
Value Measurement for Health Care - Institute For Strategy And Competitiveness
part of their business model Executives from health care insurance companies, government entities that pay for health care, or other payor organizations Leaders from pharmaceutical companies, medical device...
View Details
- 25 Feb 2015
- Lessons from the Classroom
Scholars and Students Unpack the Digital Business Revolution
transformation to digital is being driven by two primary factors, according to Iansiti: the explosion of connected devices and expanded computing capacity in the cloud. The study of innovation View Details
- Web
FAQs - Institute For Strategy And Competitiveness
ISC’s Value-Measurement in Health Care executive education courses is a good way for leaders to understand TDABC and how they can contribute to successful completion of these costing analyses. Q: Why are so few in the View Details
- 25 May 2016
- Research & Ideas
How Consumers and Businesses are Reshaping Public Health
too often still result in decisions that take scant account of public health and whether the health of individual citizens is being advanced. When worker safety is jeopardized by unenforced building codes or exposure to harmful View Details
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
who is invested in keeping it that way. The book presents a new vision of how health care could work if it were truly designed to meet consumer needs, creating a call to action on how to demand and help create such a system. A wake-up...
View Details
- August 2009 (Revised June 2015)
- Case
MINTing Innovation at NewYork-Presbyterian (A)
By: Richard G. Hamermesh and David Kiron
Several top surgeons at NewYork-Presbyterian Hospital (NYP) are receiving financial and administrative support to advance their surgical device inventions through the earliest stages of commercialization.
View Details
Keywords:
Health Care;
Innovation & Entrepreneurship;
Hospital;
Entrepreneurship;
Financing and Loans;
Investment;
Health Care and Treatment;
Innovation and Invention;
Intellectual Property;
Commercialization;
Health Industry;
Health Industry;
New York (state, US)
Hamermesh, Richard G., and David Kiron. "MINTing Innovation at NewYork-Presbyterian (A)." Harvard Business School Case 810-004, August 2009. (Revised June 2015.)
- 25 Jul 2017
- First Look
First Look at New Research and Ideas: July 25, 2017
case: https://cb.hbsp.harvard.edu/cbmp/product/902412-PDF-ENG Harvard Business School Case 117-012 ATH Technologies: Making the Numbers An exercise that takes students through five stages of growth in an entrepreneurial start-up in the View Details
Keywords:
Carmen Nobel
- 19 Feb 2019
- First Look
New Research and Ideas, February 19, 2019
We conclude with directions for future research. Publisher's link: https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=55591 February 2019 American Economic Journal: Economic Policy Does It Matter If Your Health Insurer Is For Profit? Effects of Ownership on Premiums,...
View Details
Keywords:
Sean Silverthorne
- Web
Strategy for Health Care Delivery - Institute For Strategy And Competitiveness
rather than medical specialties Optimize costs through accurate measurement and reporting Apply the concept of Time-Driven Activity-Based Costing (TDABC) to measure health care costs View Details
- 28 Mar 2023
- Research & Ideas
The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation
vaccines are now widely considered safe and effective, the public’s fears were a reflection of a broader hesitation about faster-than-expected R&D processes, Stern says. “Regulation in health care product markets exists for a very...
View Details